Cargando…

Involvement of Surfactant Protein D in Ebola Virus Infection Enhancement via Glycoprotein Interaction

Since the largest 2014–2016 Ebola virus disease outbreak in West Africa, understanding of Ebola virus infection has improved, notably the involvement of innate immune mediators. Amongst them, collectins are important players in the antiviral innate immune defense. A screening of Ebola glycoprotein (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Favier, Anne-Laure, Reynard, Olivier, Gout, Evelyne, van Eijk, Martin, Haagsman, Henk P., Crouch, Erika, Volchkov, Viktor, Peyrefitte, Christophe, Thielens, Nicole M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356362/ https://www.ncbi.nlm.nih.gov/pubmed/30587835 http://dx.doi.org/10.3390/v11010015

Ejemplares similares

Protective Effect of Surfactant Protein D in Pulmonary Vaccinia Virus Infection: Implication of A27 Viral Protein
por: Julien, Perino, et al.
Publicado: (2013)

Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication
por: Reynard, Olivier, et al.
Publicado: (2015)

The Human Metapneumovirus Matrix Protein Stimulates the Inflammatory Immune Response In Vitro
por: Bagnaud-Baule, Audrey, et al.
Publicado: (2011)

Proteolytic Processing of Filovirus Glycoproteins
por: Volchkov, Viktor, et al.
Publicado: (2018)

Editorial: Updates on the role of surfactant proteins A and D in innate immune responses
por: Madan, Taruna, et al.
Publicado: (2022)

Molecular rationale for antibody-mediated targeting of the hantavirus fusion glycoprotein
por: Rissanen, Ilona, et al.
Publicado: (2020)

Surfactant protein-D and pulmonary host defense
por: Crouch, Erika C
Publicado: (2000)

Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG
por: Pyankov, Oleg V., et al.
Publicado: (2017)

Shed GP of Ebola Virus Triggers Immune Activation and Increased Vascular Permeability
por: Escudero-Pérez, Beatriz, et al.
Publicado: (2014)

Recombinant Antibodies to the Ebola Virus Glycoprotein
por: Panina, A. A., et al.
Publicado: (2017)

Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein
por: Paparisto, Ermela, et al.
Publicado: (2021)

Toremifene interacts with and destabilizes the Ebola virus glycoprotein
por: Zhao, Yuguang, et al.
Publicado: (2016)

The Pulmonary Surfactant System: Biochemical and Clinical Aspects
por: Creuwels, L. A. J. M., et al.
Publicado: (1997)

Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum
por: Bhattacharyya, Suchita, et al.
Publicado: (2011)

The Ebola Virus Glycoprotein Contributes to but Is Not Sufficient for Virulence In Vivo
por: Groseth, Allison, et al.
Publicado: (2012)

Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism
por: Vande Burgt, Nathan H., et al.
Publicado: (2015)

Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein
por: Rodríguez-Martínez, Luis Mario, et al.
Publicado: (2015)

The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells
por: Edri, Avishay, et al.
Publicado: (2018)

Ebola Virus Glycoprotein Domains Associated with Protective Efficacy
por: Bhatia, Bharti, et al.
Publicado: (2021)

An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells
por: Cai, Yingyun, et al.
Publicado: (2021)

Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone
por: Manno, Daniela, et al.
Publicado: (2022)

Enhanced Antiviral Activity of Human Surfactant Protein D by Site-Specific Engineering of the Carbohydrate Recognition Domain
por: van Eijk, Martin, et al.
Publicado: (2019)

Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing
por: Shrivastava-Ranjan, Punya, et al.
Publicado: (2018)

An exploration of conditions proposed to trigger the Ebola virus glycoprotein for fusion
por: Fénéant, Lucie, et al.
Publicado: (2019)

In silico-based vaccine design against Ebola virus glycoprotein
por: Dash, Raju, et al.
Publicado: (2017)

Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry
por: Wang, Jizhen, et al.
Publicado: (2011)

Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
por: Marzi, Andrea, et al.
Publicado: (2016)

Role of Soluble Innate Effector Molecules in Pulmonary Defense against Fungal Pathogens
por: Ordonez, Soledad R., et al.
Publicado: (2017)

Comparative Analysis of Ebola Virus Glycoprotein Interactions With Human and Bat Cells
por: Kühl, Annika, et al.
Publicado: (2011)

Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins
por: Wu, Shipo, et al.
Publicado: (2012)

Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic
por: Diehl, William E., et al.
Publicado: (2016)

The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development
por: Zhu, Wenjun, et al.
Publicado: (2019)

Ebola sGP—The first viral glycoprotein shown to be C-mannosylated
por: Falzarano, Darryl, et al.
Publicado: (2007)

Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoprotein
por: Yi, Dongrong, et al.
Publicado: (2022)

Concomitant Human Infections with 2 Cowpox Virus Strains in Related Cases, France, 2011
por: Ducournau, Corinne, et al.
Publicado: (2013)

BoHV-4-based vector delivering Ebola virus surface glycoprotein
por: Rosamilia, Alfonso, et al.
Publicado: (2016)

Purification and characterization of monoclonal IgG antibodies recognizing Ebola virus glycoprotein
por: Han, Baek-Sang, et al.
Publicado: (2018)

Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection
por: Iampietro, Mathieu, et al.
Publicado: (2017)

Development of an imaging system for visualization of Ebola virus glycoprotein throughout the viral lifecycle
por: Furuyama, Wakako, et al.
Publicado: (2022)

Ebola virus shed glycoprotein is toxic to human T, B, and natural killer lymphocytes
por: Perez-Valencia, Luis J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dsesgpifqc550rbla3af4ib09f